Assenagon Asset Management S.A. Sells 37,841 Shares of Avantor, Inc. (NYSE:AVTR)

Assenagon Asset Management S.A. lowered its holdings in Avantor, Inc. (NYSE:AVTR) by 28.3% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 95,674 shares of the company’s stock after selling 37,841 shares during the quarter. Assenagon Asset Management S.A.’s holdings in Avantor were worth $2,475,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Graypoint LLC grew its position in shares of Avantor by 3.8% in the 1st quarter. Graypoint LLC now owns 11,414 shares of the company’s stock worth $292,000 after buying an additional 423 shares during the last quarter. Intech Investment Management LLC grew its position in shares of Avantor by 1.8% in the 2nd quarter. Intech Investment Management LLC now owns 29,068 shares of the company’s stock worth $616,000 after buying an additional 514 shares during the last quarter. Arizona State Retirement System grew its position in shares of Avantor by 0.3% in the 2nd quarter. Arizona State Retirement System now owns 186,567 shares of the company’s stock worth $3,955,000 after buying an additional 528 shares during the last quarter. Veracity Capital LLC grew its position in Avantor by 1.0% during the 3rd quarter. Veracity Capital LLC now owns 52,359 shares of the company’s stock worth $1,355,000 after purchasing an additional 543 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC grew its position in Avantor by 2.8% during the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 26,921 shares of the company’s stock worth $571,000 after purchasing an additional 733 shares during the last quarter. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Avantor Stock Performance

AVTR opened at $22.37 on Friday. The company has a debt-to-equity ratio of 0.89, a current ratio of 1.59 and a quick ratio of 1.05. The firm has a fifty day moving average price of $25.26 and a 200 day moving average price of $24.19. Avantor, Inc. has a 1 year low of $17.06 and a 1 year high of $28.00. The stock has a market cap of $15.20 billion, a P/E ratio of 57.36, a P/E/G ratio of 2.93 and a beta of 1.33.

Analyst Ratings Changes

Several analysts have weighed in on AVTR shares. Citigroup downgraded shares of Avantor from a “buy” rating to a “neutral” rating and dropped their target price for the stock from $30.00 to $23.00 in a research report on Wednesday, July 10th. TD Cowen boosted their target price on shares of Avantor from $28.00 to $31.00 and gave the stock a “buy” rating in a research report on Monday, July 29th. Wells Fargo & Company dropped their target price on shares of Avantor from $30.00 to $28.00 and set an “overweight” rating on the stock in a research report on Monday. Robert W. Baird dropped their target price on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating on the stock in a research report on Monday. Finally, UBS Group dropped their target price on shares of Avantor from $30.00 to $29.00 and set a “buy” rating on the stock in a research report on Tuesday, October 8th. Three equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $27.57.

Insider Activity at Avantor

In related news, CAO Steven W. Eck sold 3,525 shares of the business’s stock in a transaction on Thursday, September 5th. The shares were sold at an average price of $25.06, for a total value of $88,336.50. Following the completion of the transaction, the chief accounting officer now directly owns 29,544 shares in the company, valued at $740,372.64. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 1.50% of the company’s stock.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.